Matthew Turner, President of Patient Affordability, Paysign, touches on how evolving payer tactics appear to be pushing ...
Matthew Turner, President of Patient Affordability, Paysign discusses how next-generation copay assistance appears to be less about consolidating services under one vendor and more about assembling ...
In today's Pharmaceutical Executive Daily, a federal judge blocks RFK Jr.'s reconstituted vaccine advisory committee and ...
Excalipoint Therapeutics closed an oversubscribed $68.7 million seed financing, one of the largest early-stage rounds for a Chinese biotechnology company, to advance its pipeline of six T-cell engager ...
Manufacturers are rethinking patient assistance program architecture amid the economic pressures of the Inflation Reduction Act.
Icotyde is the first targeted oral peptide IL‑23 receptor antagonist, designed to interrupt a core psoriasis inflammatory axis while avoiding injection-based administration typical of IL‑23 biologics.
Vera Pomerantseva, Director of Product Management for RBQM, eClinical Solutions, mentions how eClinical Solutions positioned ...
Arthur G. Cook is Principal, ZS Associates.
New technologies are impacting the speed-to-therapy within hub services. In a conversation with Pharmaceutical Executive, ...
Patel explores how automation and AI are accelerating speed-to-therapy within hub services, the strategic implications of ...
The court found ACIP member replacements were executed without required FACA processes, undermining transparency, balanced representation, and public participation in federal vaccine advisory work. A ...
Vera Pomerantseva, Director of Product Management for RBQM, eClinical Solutions, touched on AI's growing role in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results